It’s only fair to share… Sinovac COVID-19 vaccine, CoronaVac, PiCoVacc CoronaVac, also known as the Sinovac COVID-19 vaccine,[1] is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech.[2] It has been in Phase III clinical trials in Brazil,[3] Chile,[4] Indonesia,[5] the Philippines,[6] and Turkey.[7] It relies on traditional technology similar to BBIBP-CorV and BBV152, other inactivated-virus COVID-19 vaccines in Phase III trials.[8] CoronaVac does not need to be frozen, and both the …
Category «Uncategorized»
Johnson & Johnson COVID-19 vaccine, JNJ 78436735
It’s only fair to share… Johnson & Johnson COVID-19 vaccine, JNJ 78436735 Ad26.COV2.S JNJ-78436735 Ad26COVS1 VAC31518 UNII: JT2NS6183B https://www.onesourcedocs.com/wp-content/uploads/2021/03/Janssen_Pharmaceuticals_SDS_Ad26COVS1_100000015774_v3_5_202102_nr-1.pdf NAME DOSAGE STRENGTH ROUTE LABELLER MARKETING START MARKETING END Covid-19 Vaccine Janssen Injection, suspension 0.95 Inf. U Intramuscular Janssen Cilag International Nv 2021-03-17 Not applicable Janssen COVID-19 Vaccine Injection, suspension 50000000000 {VP}/0.5mL Intramuscular Janssen Products, LP …
NOVAWAX, NVX-CoV2373,
It’s only fair to share… NOVAWAX NVX-CoV2373 SARS-CoV-2 rS Nanoparticle Vaccine MCDC OTA agreement number W15QKN-16-9-1002 Novavax COVID-19 vaccine, Coronavirus disease 19 infection SARS-CoV-2 rS, TAK 019 Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it had an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal …
BBIBP-CorV, Sinopharm COVID-19 vaccine
It’s only fair to share… BBIBP-CorV, Sinopharm COVID-19 vaccine CAS Number 2503126-65-4 Inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) Purified inactivated SARS-CoV-2 Vaccine ref Lancet Infectious Diseases (2021), 21(1), 39-51. BBIBP-CorV, also known as the Sinopharm COVID-19 vaccine,[1] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. In late December 2020, it was in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 …
Sitravatinib
It’s only fair to share… Sitravatinib 1-N‘-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1-N’-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide MG-91516 1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N’-(4- fluorophenyl)- N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide シトラバチニブ; ситраватиниб , سيترافاتينيب , 司曲替尼 , Formula C33H29F2N5O4S Cas 1123837-84-2 Mol weight 629.6763 MG-516 Sitravatinib (MGCD516) UNII-CWG62Q1VTB CWG62Q1VTB MGCD-516 MGCD516 Antineoplastic, Receptor tyrosine kinase inhibitor Sitravatinib (MGCD516) is an experimental drug for the treatment of cancer. It is a small molecule inhibitor of multiple tyrosine kinases. Sitravatinib is being …
Anamorelin hydrochloride
It’s only fair to share… Anamorelin 249921-19-5 [RN] 3-{(2R)-3-{(3R)-3-Benzyl-3-[(trimethylhydrazino)carbonyl]-1-piperidinyl}-2-[(2-methylalanyl)amino]-3-oxopropyl}-1H-indole 3-Piperidinecarboxylic acid, 1-[(2R)-2-[(2-amino-2-methyl-1-oxopropyl)amino]-3-(1H-indol-3-yl)-1-oxopropyl]-3-(phenylmethyl)-, 1,2,2-trimethylhydrazide, (3R)- 8846 анаморелин أناموريلين 阿那瑞林 Formula C31H42N6O3 Molar mass 546.716 g·mol−1 .HCL Anamorelin hydrochloride 3-Piperidinecarboxylic acid, 1-[(2R)-2-[(2-amino-2-methyl-1-oxopropyl)amino]-3-(1H-indol-3-yl)-1-oxopropyl]-3-(phenylmethyl)-, 1,2,2- trimethylhydrazide, hydrochloride (1:1), (3R)- Formula C31H42N6O3. HCl CAS 861998-00-7 Mol weight 583.1645 APPROVED JAPAN PMDA Adlumiz, 22/1/2021 アナモレリン塩酸塩 ONO-7643, RC-1291, ST-1291 Antineoplastic, Growth hormone secretagogue receptor (GHSR) agonist Anamorelin is …
DASATINIB
It’s only fair to share… DASATINIB ダサチニブ水和物 BMS 354825 863127-77-9 HYDRATE, USAN, BAN INN, JAN UNII: RBZ1571X5H 302962-49-8 FREE FORM Dasatinib anhydrous USAN, INN Molecular Formula, C22-H26-Cl-N7-O2-S.H2-O, Molecular Weight, 506.0282 T6N DNTJ A2Q D- DT6N CNJ B1 FM- BT5N CSJ DVMR BG F1 [WLN] X78UG0A0RN дазатиниб [Russian] [INN] دازاتينيب [Arabic] [INN] 达沙替尼 [Chinese] [INN] 1132093-70-9 [RN] 302962-49-8 [RN] 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]- 8712 9966762 [Beilstein] A pyrimidine and thiazole derived …
Norepinephrine bitartrate
It’s only fair to share… Norepinephrine bitartrate Arterenol bitartrate RN: 3414-63-9 FREE FORM 138-65-8 UNIIIFY5PE3ZRW R FORM CAS Number108341-18-0, 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate (9CI) Arterenol, tartrate, monohydrate (6CI) L-Noradrenaline bitartrate monohydrate Levarterenol bitartrate monohydrate WeightAverage: 337.281 Chemical FormulaC12H19NO10 (+-)-Arterenol bitartrate (+-)-Noradrenaline bitartrate (+-)-Norepinephrine bitartrate (2R,3R)-2,3-dihydroxybutanedioic acid 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol hydrate …
COVAXIN, BBV 152
It’s only fair to share… COVAXIN CAS 2501889-19-4 Whole-Virion Inactivated SARS-CoV-2 Vaccine UNII76JZE5DSN6 BBV 152 A whole virion inactivated COVID-19 vaccine candidate derived from SARS-CoV-2 strain NIV-2020-770 REF medRxiv (2020), 1-21. bioRxiv (2020), 1-32. BBV152 (also known as Covaxin) is an inactivated virus-based COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. BBV152 is a vaccine candidate created by the Indian …
Lenalidomide hydrate
It’s only fair to share… Lenalidomide hydrate レナリドミド水和物 An immunomodulator. CC-5013 hemihydrate 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, hydrate (2:1) (+/-)-2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, hydrate (2:1) Formula (C13H13N3O3)2. H2O CAS 847871-99-2 Mol weight 536.5365 EMA APPROVED 2021/2/11, Lenalidomide KRKA Research Code：CDC-501; CC-5013 Trade Name：Revlimid® MOA：Angiogenesis inhibitor Indication：Myelodysplastic syndrome (MDS); Mantle cell lymphoma (MCL); Multiple myeloma (MM) Status：Approved Company：Celgene (Originator) Sales：$5,801.1 Million (Y2015); $4,980 Million (Y2014);; $4280 …